FDA.reportPublic FDA data

eprosartan 600 MG / HCTZ 12.5 MG Oral Tablet [Teveten HCT]

RxCUI
352335
RxNorm name
eprosartan 600 MG / HCTZ 12.5 MG Oral Tablet [Teveten HCT]
Display name
eprosartan 600 MG / HCTZ 12.5 MG Oral Tablet [Teveten HCT]
Full name
eprosartan 600 MG / HCTZ 12.5 MG Oral Tablet [Teveten HCT]
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:16

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b1dfcac3-ef66-4d3e-9d58-37d3f516eb31TEVETEN HCT 600 MG / 12.5 MG Oral Tablet [PSN] · eprosartan 600 MG / hydrochlorothiazide 12.5 MG Oral Tablet [Teveten HCT] [SBD] · eprosartan 600 MG / HCTZ 12.5 MG Oral Tablet [Teveten HCT] [SY] · Teveten HCT (eprosartan 600 MG / HCTZ 12.5 MG) Oral Tablet [SY]42TEVETEN ® HCT (eprosartan mesylate/hydrochlorothiazide)600/12.5mg 600/25mg20120103